Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT02561533

Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma

Conditions: Papillary Thyroid Carcinoma

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 53

Sponsor: University of Aarhus

Location: Aarhus University Hospital Aarhus C

Summary

Immunohistochemical detection of the BRAF-V600E mutation on pre-operative fine needle aspiration biopsy (FNAB) from patients suspected for papillary thyroid carcinoma, using the mutation specific antibody VE1.

Eligibility Criteria

Inclusion Criteria: * Bethesda system of reporting thyroid cytology (BSRTC) group 5-6 on pre-operative FNAB from the nodule (\>1cm) * Undergoing thyroid surgery (histology of index nodule) Exclusion Criteria: * Not undergoing thyroid surgery

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02561533). StuddyBuddy aggregates publicly available trial information.